JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 28, 2004; DOI: 10.1124/jpet.104.068676


0022-3565/04/3103-1027-1034$20.00
JPET 310:1027-1034, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.068676v1
310/3/1027    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zorrilla, E. P.
Right arrow Articles by Koob, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zorrilla, E. P.
Right arrow Articles by Koob, G. F.

BEHAVIORAL PHARMACOLOGY

Human Urocortin 2, a Corticotropin-Releasing Factor (CRF)2 Agonist, and Ovine CRF, a CRF1 Agonist, Differentially Alter Feeding and Motor Activity

Eric P. Zorrilla, Lindsay E. Reinhardt, Glenn R. Valdez, Koki Inoue, Jean E. Rivier, Wylie W. Vale, and George F. Koob

Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California (E.P.Z., L.E.R., G.R.V., K.I., G.F.K.); Department of Neuropsychiatry, Osaka City University Medical School, Osaka, Japan (K.I.); and Peptide Biology Laboratory, The Salk Institute for Biological Sciences, La Jolla, California (J.E.R., W.W.V.)

Two corticotropin-releasing factor (CRF) receptor families have been identified (CRF1 and CRF2). Whereas anxiogenic-like roles for the CRF1 receptor have been identified, behavioral functions of the CRF2 receptor remain obscure. Urocortin 2 (Ucn 2), a CRF-related peptide that selectively binds CRF2 receptors, was recently identified and recognized for its central anorectic properties. The present study tested the hypothesis that the anorexigenic mode of action of Ucn 2 differed from that of ovine CRF (oCRF), a preferential CRF1 receptor agonist. The behavioral effects of intracerebroventricular administration of Ucn 2 were compared with those of oCRF in nondeprived male Wistar rats (n = 102). Ucn 2 reduced 6-h food and water intake at doses that did not induce visceral illness (0.1, 1, and 10 µg), as indicated by kaolin intake. Ucn 2 retained its potent anorectic activity in rats receiving a highly palatable cafeteria diet, preferentially reducing intake of carbohydrate (CHO)-rich items while sparing intake of mixed-fat/CHO items. In contrast to Ucn 2, oCRF (10 µg) suppressed 6-h intake of cafeteria diet-fed rats without regard to macronutrient composition. Rather, oCRF most potently suppressed intake of preferred food items. Whereas oCRF had short-onset motor-activating effects, Ucn 2 had nondose-dependent, delayed-onset motor-suppressing effects. Thus, central infusion of a CRF2 receptor agonist suppressed intake of both bland and palatable diets without inducing behavioral arousal or malaise, and the profile of anorexigenic effects qualitatively differed from those of a CRF1 receptor agonist. The results suggest the existence of distinct forms of CRF1- and CRF2-mediated anorexia.


Received March 18, 2004; accepted April 28, 2004.

Address correspondence to: Dr. Eric P. Zorrilla, Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail: ezorrilla{at}scripps.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhao, G. R. Valdez, E. M. Fekete, J. E. Rivier, W. W. Vale, K. C. Rice, F. Weiss, and E. P. Zorrilla
Subtype-Selective Corticotropin-Releasing Factor Receptor Agonists Exert Contrasting, but Not Opposite, Effects on Anxiety-Related Behavior in Rats
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. P. Bakshi, S. M. Newman, S. Smith-Roe, K. A. Jochman, and N. H. Kalin
Stimulation of Lateral Septum CRF2 Receptors Promotes Anorexia and Stress-Like Behaviors: Functional Homology to CRF1 Receptors in Basolateral Amygdala
J. Neurosci., September 26, 2007; 27(39): 10568 - 10577.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. Cottone, V. Sabino, T. R. Nagy, D. V. Coscina, and E. P. Zorrilla
Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2
J. Physiol., September 1, 2007; 583(2): 487 - 504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Legendre, E. Papakonstantinou, M.-C. Roy, D. Richard, and R. B. S. Harris
Differences in response to corticotropin-releasing factor after short- and long-term consumption of a high-fat diet
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1076 - R1085.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Henry, W. Vale, and A. Markou
The Effect of Lateral Septum Corticotropin-Releasing Factor Receptor 2 Activation on Anxiety Is Modulated by Stress
J. Neurosci., September 6, 2006; 26(36): 9142 - 9152.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.